Navigation Links
ImaginAb, Inc. and Dainippon Seiki (DNS) Co., Ltd. Conclude Technology Development Agreement for Automated Chemistry Systems
Date:4/11/2011

LOS ANGELES and KYOTO, Japan, April 11, 2011 /PRNewswire/ -- ImaginAb, Inc. and Dainippon Seiki Co., Ltd. have concluded a technology agreement around the development of automated chemistry systems for fluorination of proteins and peptides for diagnostic imaging with positron emission tomography (PET).

"Over the past 18 months, our academic and pharma client base has dramatically increased and we have been developing and in-licensing novel fluorine chemistries to streamline labeling of proteins and peptides for targeted molecular imaging with PET," said Dr. Christian Behrenbruch, CEO of ImaginAb. "DNS has tremendous automation and instrumentation experience in the chemistry / radiochemistry domain and we are delighted to be working with such a dynamic and innovative organization to deliver new solutions to our customers."

Mr. Masayoshi Sugihara, President of DNS commented, "We have seen a significant increase in the interest level in novel peptides and biologics for diagnostic imaging and believe in the commercial importance of automated fluorine chemistry to drive this industry ahead. We are pleased to be collaborating with ImaginAb to develop high-throughput fluorination solutions that will be suitable for both pre-clinical and (eventually) clinical use."*

About ImaginAb

Founded in 2007 by UCLA Faculty (Drs. Robert Reiter, Anna Wu and Christian Behrenbruch), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products. For more information about ImaginAb, visit www.imaginab.com.

About DNS

Based in Kyoto, Japan, Dainippon Seiki (DNS) Co., Ltd. is an innovation leader in automation, robotics and high-precision instrumentation. DNS is a best-in-class provider of fully automated synthesis, diagnostic/inspection and robotic assembly systems with solutions for both life sciences/pharmaceutical and semiconductor industries. For more information about DNS, visit www.dnseiki.co.jp.

*The products and services described in this press release have not attained regulatory approval for clinical use in Japan or the USA.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Anna Wu

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91513


'/>"/>
SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia
2. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
3. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
4. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
5. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
6. Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
7. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
8. Published Study Concludes: Vented Baby Bottles Protect Essential Nutrients in Breast Milk and Formula
9. Independent Study Concludes Medicare Competitive Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities
10. Mr. Jean-Pierre Garnier Concludes his Mission at the Pierre Fabre Company
11. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... --> --> ... Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... Ophthalmology, Gynecology) - Global Forecasts to 2020", published by ... forecast period of 2015 to 2020. The market is ... of 10.5% from 2015 to 2020. Browse ...
(Date:2/8/2016)... , Feb. 8, 2016   HighPoint ... November Research Group (NRG),s pharmacovigilance technology services division.  ... consulting services and an Oracle Argus Specialized partner, ... to Life Sciences companies. --> ... expands HighPoint,s life sciences capabilities and provides a ...
(Date:2/8/2016)...  As part of a major growth and expansion initiative, ... Lori Chmura as President of Dune Inc., its ... Chmura,s extensive experience in the medical device space will play ... --> --> In ... sales, marketing and operational functions in the U.S. She is ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates ... vital new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse ... from intimate abuse. To support all those victimized by the fear of violence in ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... program serving the greater Venice, FL area, has initiated a fundraiser for a ... car accident just four days after Christmas. To support this beautiful child who ...
(Date:2/8/2016)... (PRWEB) , ... February 08, ... ... and security executive networking and relationship-marketing firm, announced today that nominations will ... Information Security Executive® (ISE®) West Awards. , Awards include the Information ...
(Date:2/8/2016)... Pekin, IL (PRWEB) , ... February 08, 2016 ... ... debilitating conditions that co-occur frequently. While a significant number of women and men ... PTSD, not the trauma itself, that best predicts the development of an eating ...
(Date:2/8/2016)... ... ... the Rocky Mountain region’s longest running and impressive garden and home show where you ... the most incredible gardens and home improvement experts that attend this amazing show. ... 700 14th St. Denver CO, is an exciting event that Performance Mobility has enjoyed ...
Breaking Medicine News(10 mins):